This event is now fully booked, if you wish to go on the waiting list please email us.

The Royal College of Pathologists (RCPath) is hosting this new conference with the National Cancer Research Institute (NCRI) initiative, CM-Path (Cellular molecular pathology initiative). CM-Path aims to achieve the change needed to support academic cellular molecular pathology in the UK and make the resulting benefits available to the wider research community.

PROGRAMME

09.30     Registration and Coffee

10.00     Introduction and Welcome - Dr Karin Oien and Dr Alex Freeman

10.15     Strategic importance of Pathology in Clinical Trials: towards Precision Medicine? Dr Rowena Sharpe

10.35     Role of NCRI and Clinical Studies Groups - Ms Nicola Keat

10.55     Overview of potential pathology contribution to Clinical Trials – from inception to completion - Professor Gary Middleton and Dr Emily Shaw

11.45     Using tissue in Clinical Trials – rules and regulations, storage and access - Dr Bridget Wilkins

12.15     Lunch

13.05     Pathology-based testing of tissues in Clinical Trials – Performance, Standardisation and Quality Control - Professor Adrienne Flanagan

13.35     Issues in interpretation of pathology tests - Dr Max Robinson

14.05     Training - What should a Clinical Trial Pathologists know? - Professor Manuel Salto-Tellez

14.25     Funding opportunities for Clinical Trial Pathologists - Professor Ian Cree

14.45     Coffee Break

15.00     Break-out Groups:

Getting started in Clinical Trials as a Pathology Trainee or Consultant CM-Path Faculty

Clinical Trials in Practice – lessons learned CM-Path Faculty

16.00     Drinks and networking opportunity

16.30     Close